TMK1 Antibody

What is TMK1 and why are TMK1 antibodies important research tools?

TMK1 is a leucine-rich repeat receptor-like kinase (LRR-RLK) that functions as a key component in auxin signaling and participates in cross-talk between auxin and ABA signaling pathways. TMK1 is involved in multiple developmental processes and environmental responses in plants .

TMK1 antibodies are essential tools that enable researchers to detect, quantify, and isolate TMK1 protein from plant tissues. These antibodies have been instrumental in revealing TMK1's interactions with various proteins including ABI1/2 (negative regulators of ABA signaling), ABP1 (Auxin Binding Protein 1), ABLs (ABP1-like proteins), and TMK INTeractors (TINTs) . Without specific TMK1 antibodies, many of these interactions and signaling mechanisms would remain undiscovered.

What experimental validation steps should be performed when using a new TMK1 antibody?

When working with a new TMK1 antibody, the following validation steps are recommended:

• Perform western blotting with wild-type plants and tmk1 mutants to confirm antibody specificity - the specific band should be absent in the mutant .

• Test cross-reactivity with other TMK family members (TMK2, TMK3, TMK4) by including protein extracts from single tmk mutants for each family member .

• Conduct a peptide competition assay by pre-incubating the antibody with the immunizing peptide before immunoblotting to verify specific binding.

• Compare signal intensity between wild-type and TMK1-overexpression lines to confirm correlation with protein levels.

• Validate subcellular localization patterns detected by immunofluorescence against established TMK1-reporter lines such as pTMK1:TMK1-GFP .

How can TMK1 antibodies be used to study TMK1-dependent auxin responses?

TMK1 antibodies can be employed to investigate TMK1-dependent auxin responses through several approaches:

• Protein level analysis: Monitor TMK1 protein levels in response to auxin treatment using western blotting with anti-TMK1 antibodies.

• Phosphorylation dynamics: Assess TMK1 activation status using Phos-tag gel electrophoresis or Phos-tag Biotin Probe binding analysis, which have demonstrated that auxin (10 nM IAA, 1 hour) induces TMK1 phosphorylation in plant roots .

• Protein-protein interactions: Utilize co-immunoprecipitation with TMK1 antibodies to isolate and identify auxin-dependent interaction partners. This approach has revealed interactions between TMK1 and ABI1/2 phosphatases, which are enhanced by auxin treatment .

• Subcellular localization: Employ immunofluorescence microscopy to track TMK1 localization changes following auxin treatment.

• Complex formation studies: Use native PAGE followed by immunoblotting with TMK1 antibodies to analyze auxin-induced changes in TMK1 complex formation.

How can I optimize co-immunoprecipitation protocols to detect TMK1 interactions with weak binding partners?

Detecting weak or transient TMK1 interactions requires optimized co-immunoprecipitation (Co-IP) protocols:

• Crosslinking approach: Stabilize transient interactions by treating plant tissues with membrane-permeable crosslinkers (1-2 mM DSP for 30 minutes) before extraction.

• Buffer optimization:

  • Use 0.5-1% mild detergent (NP-40 or Triton X-100)

  • Include protease inhibitor cocktail and phosphatase inhibitors (10 mM NaF, 1 mM Na₃VO₄)

  • Add 1 mM DTT to maintain protein structure

  • Adjust salt concentration (100-150 mM for stable complexes; 50-75 mM for weaker interactions)

• Hormone pre-treatment: Enhance certain TMK1 interactions by treating samples with appropriate hormones (100 nM NAA or 10 nM IAA), which has been shown to promote interaction between TMK1 and its binding partners .

• Two-step IP: Perform sequential immunoprecipitation with different antibodies (e.g., anti-TMK1 followed by anti-interactor) to increase specificity.

• Bead selection: Use magnetic Protein A/G beads for cleaner results compared to agarose beads, and pre-clear lysates before adding antibodies.

This optimized approach has successfully identified TMK1 interactions with TINT proteins and ABL proteins in recent studies .

What methods can distinguish between TMK1 and other TMK family members in experimental settings?

Distinguishing between the four TMK family members (TMK1-4) is crucial for accurate interpretation of experimental results:

• Antibody specificity verification: Use antibodies raised against unique regions of TMK1 that are not conserved in other TMK family members. C-terminal regions typically show greater sequence divergence than kinase domains.

• Genetic verification: Include samples from single tmk mutants (tmk1-1, tmk1-2, tmk1-3, tmk2, tmk3, tmk4-1) to confirm antibody specificity . Research has shown that TMK1 has specific functions not redundant with other TMK family members - the tmk1-1 mutant shows distinct phenotypes in auxin-enhanced ABA responses not observed in other tmk mutants .

• Peptide competition controls: Perform parallel assays with antibodies pre-incubated with peptides unique to each TMK family member to demonstrate specificity.

• Epitope tagging: Express tagged versions of specific TMK proteins (e.g., TMK1-FLAG) in tmk1 mutant backgrounds and use anti-tag antibodies for specific detection .

• Mass spectrometry validation: Analyze immunoprecipitated proteins by mass spectrometry to confirm the specific identity of the targeted TMK protein.

How can I study TMK1 phosphorylation dynamics in response to auxin treatment?

TMK1 phosphorylation is a key regulatory mechanism in auxin signaling . The following approaches can be used to study these dynamics:

• Phos-tag gel electrophoresis: Separate phosphorylated from non-phosphorylated TMK1 forms, which appear as mobility-shifted bands on western blots.

• Phos-tag Biotin Probe binding analysis: This technique has been successfully used on immunoprecipitated TMK1-FLAG proteins to detect phosphorylation changes after hormone treatment (10 nM IAA, 1 hour) .

• Time-course experiments: Capture temporal phosphorylation dynamics by sampling at multiple time points after auxin treatment (5, 15, 30, 60 minutes).

• Mass spectrometry-based phosphoproteomics: Identify specific phosphorylation sites on TMK1 and quantify changes in phosphorylation status following auxin treatment.

• Phospho-specific antibodies: Develop or obtain antibodies that specifically recognize phosphorylated residues of TMK1.

What approaches can be used to study TMK1 interactions with newly identified partners like ABLs and TINTs?

Recent research has identified novel TMK1 interacting proteins including ABLs (ABP1-like proteins) and TINTs (TMK INTeractors) . To study these interactions:

• Reciprocal co-immunoprecipitation:

  • Immunoprecipitate with anti-TMK1 antibody and detect interactors

  • Immunoprecipitate with anti-ABL or anti-TINT antibodies and detect TMK1

  • Use epitope-tagged proteins (FLAG, HA) for cleaner results

• FRET-based interaction studies:

  • Express fluorescently tagged proteins (e.g., ABL1-GFP with mCherry-TMK1)

  • Measure FRET efficiency with/without hormone treatments

  • This approach has demonstrated that auxin (100 nM NAA) promotes interaction between ABL1 and TMK1

• In situ proximity ligation assay (PLA):

  • Use antibody pairs (anti-TMK1 + anti-ABL/TINT)

  • PLA signal occurs only when proteins are in close proximity (<40 nm)

  • Visualize interaction sites directly in plant tissues

• Bimolecular Fluorescence Complementation (BiFC):

  • Fuse TMK1 and interactors to complementary fragments of fluorescent proteins

  • Co-express in plant cells to visualize interactions in vivo

  • Include hormone treatments to assess conditional interactions

How can TMK1 antibodies be used to study the role of TMK1 in auxin-ABA crosstalk?

TMK1 plays a significant role in the crosstalk between auxin and ABA signaling pathways . TMK1 antibodies can be employed to investigate this crosstalk through:

• Protein interaction studies: Use co-immunoprecipitation with TMK1 antibodies to identify and quantify interactions with ABA signaling components (e.g., ABI1/2) in the presence of different concentrations of auxin and ABA .

• Phosphorylation analysis: Examine how auxin treatment affects TMK1-mediated phosphorylation of ABA signaling components. Research has shown that TMK1 participates in the phosphorylation of ABI1/2, which are negative regulators of ABA signaling .

• Mutant complementation studies: Use TMK1 antibodies to confirm protein expression in complementation experiments. The tmk1-1 phenotype can be complemented by a genomic TMK1 fragment, restoring auxin-enhanced ABA responses .

• Subcellular localization: Employ immunofluorescence to track the co-localization of TMK1 with ABA signaling components under different hormone treatments.

• Signaling cascade analysis: Use TMK1 antibodies to track the activation of downstream ABA signaling components (e.g., SnRK2s) in response to auxin. Research has shown that auxin treatment enhances the activation of SnRK2s by ABA, which is significantly reduced in tmk1-1 mutants .

What methodological approaches can reveal TMK1's role in different developmental contexts?

TMK1 functions in multiple developmental contexts, and various methodological approaches can reveal these diverse roles:

• Developmental expression profiling:

  • Use TMK1 antibodies for western blotting across different developmental stages

  • Implement immunohistochemistry to map TMK1 distribution in various tissues

  • Compare with reporter lines (e.g., pTMK1:GUS) to validate expression patterns

• Tissue-specific analyses:

  • Microdissect specific tissues (e.g., stomata cells where TMK1 is highly expressed)

  • Extract proteins and perform immunoblotting with TMK1 antibodies

  • Conduct co-IP experiments from specific tissues to identify context-specific interactors

• Conditional phenotype analysis:

  • Examine TMK1 protein levels and modifications during specific developmental transitions

  • Correlate protein changes with phenotypes in wild-type and tmk1 mutants

  • For example, analyze TMK1's role in stomata closure, which is enhanced by auxin (2 μM IAA) in wild-type but not in tmk1-1 mutants

• Double/triple mutant analysis:

  • Generate combinations of tmk1 with other mutants (e.g., tmk1-1abi1-2abi2-2 triple mutant)

  • Use TMK1 antibodies to confirm protein absence in these genetic backgrounds

  • This approach revealed that the tmk1-1abi1-2abi2-2 mutant shows enhanced ABA response similar to abi1-2abi2-2, opposite from the tmk1-1 single mutant

How can I optimize TMK1 antibody performance for immunoblotting applications?

Achieving clean immunoblot results with TMK1 antibodies requires optimization of several parameters:

• Extraction buffer composition:

  • Include 1% Triton X-100 or NP-40 to solubilize membrane proteins

  • Add protease inhibitors (PMSF, cocktail inhibitors) to prevent degradation

  • For phosphorylation studies, include phosphatase inhibitors (10 mM NaF, 1 mM Na₃VO₄)

  • Use buffer with appropriate salt concentration (150 mM NaCl) and pH (7.5)

• Antibody specificity enhancement:

  • Pre-adsorb antibody against plant extracts from tmk1 mutants

  • Affinity-purify antibodies using recombinant TMK1 fragments

  • Use fresh antibody aliquots and avoid repeated freeze-thaw cycles

• Blocking optimization:

  • Test different blocking agents (5% non-fat milk, 3-5% BSA)

  • Extend blocking time to 2 hours at room temperature or overnight at 4°C

  • Include 0.1% Tween-20 in blocking solutions to reduce background

• Antibody incubation conditions:

  • Test dilution series (1:500 to 1:5000) to determine optimal concentration

  • Incubate with primary antibody overnight at 4°C for better specificity

  • Add 1% blocking agent to antibody solution to further reduce non-specific binding

• Washing optimization:

  • Increase wash duration (5-6 washes for 10 minutes each)

  • Use TBS-T with 0.1% Tween-20 for washing

  • For persistent background, include 0.1% SDS in one washing step

What are the critical considerations for detecting phosphorylated forms of TMK1?

Detecting phosphorylated TMK1 presents specific challenges that can be addressed through specialized approaches:

• Sample preservation:

  • Include comprehensive phosphatase inhibitor cocktails in all buffers (10 mM NaF, 1 mM Na₃VO₄, 5 mM β-glycerophosphate)

  • Process samples rapidly and maintain cold temperature throughout

  • Add 5-10 mM N-ethylmaleimide (NEM) to prevent post-lysis modifications

• Phosphorylated protein enrichment:

  • Use Phos-tag acrylamide gels to separate phosphorylated forms

  • Enrich phosphoproteins using TiO₂ or IMAC before immunoblotting

  • Implement Phos-tag Biotin Probe binding analysis for total phosphorylation assessment

• Detection strategies:

  • Apply extended exposure times for detecting low-abundance phosphorylated forms

  • Use highly sensitive chemiluminescent or fluorescent detection systems

  • Consider phospho-specific antibodies for key regulatory sites when available

• Experimental controls:

  • Include samples treated with phosphatase to confirm phosphorylation-dependent mobility shifts

  • Use kinase-dead TMK1 mutants (e.g., TMK1 K616E) as negative controls

  • Include positive controls from auxin-treated samples (10 nM IAA, 1 hour)

• Validation experiments:

  • Confirm phosphorylation sites through mass spectrometry analysis

  • Correlate phosphorylation status with biological activity through functional assays

  • Compare phosphorylation patterns between wild-type and auxin signaling mutants

How can I successfully implement immunolocalization of TMK1 in plant tissues?

Successful immunolocalization of TMK1 in plant tissues requires attention to fixation, permeabilization, and detection parameters:

• Tissue preparation:

  • Fix tissues in 4% paraformaldehyde for 1-2 hours at room temperature

  • For roots and thin tissues, reduce fixation time to 30-60 minutes

  • Choose embedding method based on required resolution (paraffin for light microscopy, LR White resin for electron microscopy)

• Antigen retrieval:

  • Perform heat-induced epitope retrieval in citrate buffer (pH 6.0)

  • For membrane proteins like TMK1, include mild detergent (0.1% Triton X-100) in retrieval solution

  • Optimize retrieval time based on tissue type (10-30 minutes)

• Blocking and permeabilization:

  • Block with 3-5% BSA in PBS with 0.1-0.3% Triton X-100

  • Extend blocking time to 2 hours at room temperature

  • For thick tissues, increase detergent concentration to ensure permeabilization

• Antibody incubation:

  • Dilute primary antibodies appropriately (1:100 to 1:500)

  • Incubate samples with primary antibody overnight at 4°C

  • Use fluorophore-conjugated secondary antibodies at 1:200-1:500 dilution

• Controls and validation:

  • Include tmk1 mutant tissues as negative controls

  • Compare antibody staining patterns with TMK1-GFP reporter lines

  • Perform peptide competition controls to confirm specificity

This approach has revealed that TMK1 is highly expressed in germinating seedlings and stomata cells, correlating with its functional roles in these developmental contexts .

What emerging technologies might enhance TMK1 protein studies beyond traditional antibody applications?

Several emerging technologies promise to expand TMK1 research capabilities:

• Proximity labeling approaches:

  • TMK1-TurboID or TMK1-APEX2 fusions to identify proximal proteins in vivo

  • BioID-based mapping of TMK1 interaction networks in different developmental contexts

  • These methods can capture weak or transient interactions missed by co-immunoprecipitation

• CRISPR-based endogenous tagging:

  • Epitope tagging of endogenous TMK1 to maintain native expression patterns

  • Split fluorescent protein tagging for visualization of protein interactions

  • Auxin-inducible degron tagging for rapid, conditional TMK1 depletion studies

• Advanced imaging techniques:

  • Super-resolution microscopy to visualize TMK1 nanoclusters in membranes

  • Single-molecule tracking with quantum dot-conjugated antibodies

  • FRET/FLIM imaging to monitor TMK1 interactions with high spatial resolution

• Structural biology approaches:

  • Cryo-electron microscopy of TMK1 complexes with interacting proteins

  • Hydrogen-deuterium exchange mass spectrometry to map interaction interfaces

  • Nanobody development for structure-function studies of TMK1

• Synthetic biology tools:

  • Optogenetic control of TMK1 dimerization and activation

  • Chemically-induced proximity systems to manipulate TMK1 interactions

  • Engineered TMK1 variants with altered specificity for mechanistic studies

These technologies will help address fundamental questions about TMK1's role in auxin perception, signal transduction, and crosstalk with other hormonal pathways.

What are the key unanswered questions about TMK1 function that could be addressed with antibody-based approaches?

Several important questions about TMK1 function remain to be addressed:

• How do different auxin concentrations affect TMK1 phosphorylation patterns and interaction networks?

  • Use phospho-specific antibodies and co-IP approaches to characterize concentration-dependent effects

  • Apply quantitative proteomics with TMK1 immunoprecipitation to identify differential interactors

  • Studies have shown that high concentrations of auxin stimulate ABA responses partially through a TMK1-based mechanism

• What is the relationship between TMK1 and ABLs in auxin perception?

  • Employ co-immunoprecipitation with TMK1 antibodies to isolate auxin-sensing complexes

  • Use FRET analysis to study the dynamics of TMK1-ABL interactions in response to auxin

  • Recent work has established that ABLs form auxin sensing complexes with TMKs

• How does TMK1 coordinate with TIR1/AFB-based auxin signaling?

  • Compare phosphorylation and activation patterns in wild-type versus tir1/afb mutants

  • Study temporal dynamics of TMK1 and TIR1/AFB pathways using time-course experiments

  • Research has shown differential effects of TMK1 versus TIR1/AFB pathways on SnRK2 activation

• What is the tissue-specific composition of TMK1 complexes during development?

  • Perform tissue-specific immunoprecipitation followed by mass spectrometry

  • Compare TMK1 interactomes between different developmental stages

  • TMK1 has been shown to be highly expressed in specific tissues like stomata cells

• How do environmental stresses modulate TMK1-dependent signaling?

  • Study TMK1 phosphorylation status and complex formation under various stress conditions

  • Investigate how stress affects TMK1's role in auxin-ABA crosstalk

  • Research has demonstrated TMK1's involvement in stress responses including stomata closure

Addressing these questions will significantly advance our understanding of TMK1's multifaceted roles in plant development and environmental responses.